.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
QuintilesIMS
AstraZeneca
Moodys
UBS
Accenture
Baxter
Teva
Mallinckrodt
Merck

Generated: June 23, 2017

DrugPatentWatch Database Preview

CARBOPLATIN Drug Profile

« Back to Dashboard

Which patents cover Carboplatin, and what generic Carboplatin alternatives are available?

Carboplatin is a drug marketed by Pliva, Mylan Labs Ltd, Hospira, Gland Pharma Ltd, Sun Pharma Global, Pliva Lachema, Actavis Totowa, Fresenius Kabi Oncol, Fresenius Kabi Usa, Teva Pharms Usa, West-ward Pharms Int, Sandoz, Cipla Ltd, Watson Labs Teva, Akorn, Pharmachemie Bv, Accord Hlthcare, Sandoz Inc, Ingenus Pharms Llc, Sanja Pharms Co, Teva Parenteral, Nanjing King-friend, and Mylan Institutional. and is included in thirty-three NDAs.

The generic ingredient in CARBOPLATIN is carboplatin. There are eighteen drug master file entries for this compound. Eleven suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the carboplatin profile page.

Summary for Tradename: CARBOPLATIN

Patents:0
Applicants:23
NDAs:33
Suppliers / Packagers: see list11
Bulk Api Vendors: see list73
Clinical Trials: see list1,876
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CARBOPLATIN at DailyMed

Pharmacology for Tradename: CARBOPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)206775-004Feb 9, 2017APRXNoNo► Subscribe► Subscribe
Mylan Institutional
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077998-002Apr 24, 2007APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077247-003Oct 21, 2004APRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077139-002Sep 21, 2005APRXNoYes► Subscribe► Subscribe
Ingenus Pharms Llc
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)208487-001Apr 26, 2017APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Chubb
Novartis
Accenture
Express Scripts
Argus Health
US Army
Chinese Patent Office
Moodys
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot